Raphael Pharmaceutical (RAPH) Times Interest Earned (2020 - 2024)
Raphael Pharmaceutical (RAPH) reported Times Interest Earned of -$0.26 for Q4 2024, down 342.79% on a YoY basis from $0.11 in Q1 2024, and down 342.79% sequentially from $0.11 in Q4 2023.
Raphael Pharmaceutical (RAPH) Times Interest Earned (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 5 years of Times Interest Earned data on file, last reported at -$0.26 in Q4 2024.
- For the quarter ending Q4 2024, Times Interest Earned fell 342.79% year-over-year to -$0.26; the trailing twelve-month figure through Dec 2024 stood at -$0.98 (up 2.04% YoY), and the FY2025 full-year result was -$0.63, up 36.14% from the prior year.
- Times Interest Earned eased to -$0.26 in Q4 2024, from $0.11 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.11 in Q4 2023 to a low of -$1.52 in Q4 2022.
- A 5-year average of -$0.71 and a median of -$0.46 in 2021 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned surged 106.95% in 2023 and plunged 342.79% in 2024, its largest moves.
- Tracing RAPH's Times Interest Earned over 5 years: stood at -$1.44 in 2020, then jumped by 67.86% to -$0.46 in 2021, then sank by 228.85% to -$1.52 in 2022, then soared by 106.95% to $0.11 in 2023, then plunged by 342.79% to -$0.26 in 2024.
- Business Quant data shows RAPH's Times Interest Earned at -$0.26 in Q4 2024, $0.11 in Q4 2023, and -$1.52 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.26 |
| Dec 31, 2023 | 0.11 |
| Dec 31, 2022 | -1.52 |
| Dec 31, 2021 | -0.46 |
| Dec 31, 2020 | -1.44 |